Devron H Char1, J Brooks Crawford. 1. The Tumori Foundation, 45 Castro Street, Suite 309, San Francisco, CA 94114, USA. devron@tumori.org
Abstract
BACKGROUND: Two cases of conjunctival carcinoma developed orbital invasion during treatment with topical medication. METHODS: This was a retrospective study from a tertiary ophthalmic oncology unit, performed after informed consent was obtained. The main outcome measurement was orbital invasion. RESULTS: Two patients treated with topical agents developed orbital invasion. CONCLUSION: While topical agents are important in treatment of conjunctival neoplasia, recurrence or deep invasion require careful monitoring.
BACKGROUND: Two cases of conjunctival carcinoma developed orbital invasion during treatment with topical medication. METHODS: This was a retrospective study from a tertiary ophthalmic oncology unit, performed after informed consent was obtained. The main outcome measurement was orbital invasion. RESULTS: Two patients treated with topical agents developed orbital invasion. CONCLUSION: While topical agents are important in treatment of conjunctival neoplasia, recurrence or deep invasion require careful monitoring.